QQ客服 官方微博 反馈留言

	Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
	Sun, Yifeng; Hou, Likun; Yang, Yu; Xie, Huikang; Yang, Yang; Li, Zhigang; Zhao, Heng; Gao, Wen; Su, Bo
刊名	ONCOTARGETS AND THERAPY
	2016
卷号	9
关键词	molecular biomarker prognosis lung adenocarcinoma
ISSN号	1178-6930
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4288468
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Sun, Yifeng,Hou, Likun,Yang, Yu,et al. Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma[J]. ONCOTARGETS AND THERAPY,2016,9.
APA	Sun, Yifeng.,Hou, Likun.,Yang, Yu.,Xie, Huikang.,Yang, Yang.,...&Su, Bo.(2016).Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.ONCOTARGETS AND THERAPY,9.
MLA	Sun, Yifeng,et al."Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma".ONCOTARGETS AND THERAPY 9(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。